Share This Page

Suvorexant Improves Sleep in Alzheimer’s

190515-sl.jpeg

AlzForum reports new Alzheimer’s results for FDA-Approved insomnia drug suvorexant (Belsomra®). Half of people with Alzheimer’s don’t sleep well, exacerbating a variety of problems. Learn about this drug’s effectiveness and safety in dementia.


ALZFORUM EXCERPT MAY 10, 2019 – Now, results of a Phase 3 trial testing Merck’s insomnia drug suvorexant, sold as Belsomra, in patients with mild to moderate Alzheimer’s disease (AD), suggest that this drug prolongs slumber, with more overall sleep time and shorter bouts of nighttime wakefulness than placebo. The drug is FDA-approved for insomnia and has been reported safe in the elderly population. Merck scientists presented this data at the American Academy of Neurology’s 71st Annual Meeting, held in Philadelphia.

Nearly half of people with Alzheimer’s can’t sleep at night, waking up more often and staying awake longer than others their age. This causes nighttime wandering, and worsens cognition and depression. Despite the burden for both patient and caregiver, many physicians do not prescribe available hypnotics, sedatives, or antipsychotics for fear of causing falls, stroke, or hastening cognitive decline.

Effective & Well Tolerated

  • Many Alzheimer’s patients have serious problems sleeping.
  • Four weeks of suvorexant nudged up nighttime slumber.
  • Results may encourage physicians to prescribe this orexin inhibitor.

“Clinicians often say they are hesitant to try suvorexant in AD patients because of insufficient data to support the efficacy and safety in this key subpopulation,” W. Joseph Herring, Merck, Kenilworth, New Jersey, who presented the results, told Alzforum. “We’ve shown that suvorexant was effective in improving sleep and generally well tolerated in patients,” he said.

“They did a really nice study,” said David Holtzman, Washington University in St. Louis. “It clearly shows the drug caused more sleep, and there was a pretty strong effect. I think it’s worth trying in some of our dementia patients with sleep problems.”

30 Minutes Before Bedtime

Suvorexant tablets are to be taken 30 minutes before bedtime. The drug targets orexin receptors in the brain. A neurotransmitter produced in the hypothalamus, orexin binds to receptors in several brain regions, and the ensuing signaling works to keep a person awake. By binding and blocking orexin receptors, suvorexant temporarily halts orexin signaling.

Some people with Alzheimer’s have high orexin levels in their cerebral spinal fluid, which is thought to contribute to the disturbance in their sleep/wake cycle (Gabelle et al., 2017). This is the first study to evaluate suvorexant in AD.

ORIGINAL ARTICLE CONTINUES On AlzForum.com AT:
Drug Reported to Help Alzheimer’s Patients Sleep Better

SOURCE:

Related:

Email me when people comment
Notify of
guest

1 Comment
Inline Feedbacks
View all comments
otto9B9otto
otto9B9otto
May 20, 2019 7:48 pm

Belsomra side effects: abnormal dreams, "Belsomra may cause serious side effects that you may not know are happening to you, including “sleep-walking” or doing other activities when you are asleep like eating, talking, having sex, or driving a car."

https://www.rxlist.com/belsomra-side-effects-drug-center.htm

I tried Belsomra, working up to 30 mg. It did not help me sleep.

Edited by:
Picture of P. Berger

P. Berger

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Share this page To

You May LIke:

Music/Movies

How Steve’s Music Outsmarted His Alzheimer’s

67-year-old Steve Goodwin refuses to let Alzheimer’s steal his music. Though he can no longer play the beautiful songs he composed for his wife, see him rescue their music with the help of a fantastic friend and professional pianist.

Read More »
Share to Facebook
Twitter
LinkedIn

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Visit Alzheimer's Weekly On

1
0
Would love your thoughts, please comment.x
()
x
News, Treatments, Care Tips, Diet

Alzheimer's & Dementia Weekly Newsletter: Free

Free. Care & Treatment. Research & Prevention

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

News to Get at the Truth

Subscribe To Our Weekly Newsletter